Researchers at the University of North Carolina use automated, high throughput ultrasound and acoustic angiography as an alternative to MRI for tracking glioblastoma in mice.
These results highlight the potential of ultrasound imaging using the Vega™ for tracking tumor progression particularly in later stages when tumors are more easily detectable. Furthermore, these findings suggest that the Vega system could be used in drug discovery research to prioritize compounds for further evaluation before committing to MRI, which is more time-consuming and expensive.
For research use only. Not for use in diagnostic procedures
Assessing murine glioblastoma growth: a comparative study of ultrasound and MRI imaging modalities